WearLinq eWave Patch Study
Wearlinq
Summary
This study it to evaluate the usability of the WearLinq eWave patch in a general adult population.
Description
Once eligibility is determined, participants will receive and apply the WearLinq patch for 7 consecutive days (or until an endpoint is met). A subset of subjects will be asked to participate in an Extended Use Cohort (30 days).
Eligibility
- Age range
- 18+ years
- Sex
- All
- Healthy volunteers
- Yes
Inclusion Criteria: * Adult \>18 years old and able to consent * Capable of using a smartphone app * Willing to shave patch area if needed Exclusion Criteria: * Planning to undergo an MRI during the study period * Known allergic reaction to adhesives or hydrogels or with family history of adhesive skin allergies, or any other dermatological conditional that could confound placement or results * Presence of pacemaker, ICD or other implanted electronic devices * Open wounds, lesions or infected or inflamed areas of skin at the placement site (left-center of chest/sternum) * Pregnant or intend…
Interventions
- DeviceeWave Patch
This device is a wearable multi-channel ECG monitoring device for continuous cardiac rhythm tracking.
Location
- ABio Clinical Research PartnersNew London, North Carolina